ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998

Cell Culture ID Offered By NIC

January 7, 1983

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Letters: Alternatives Needs Scrutiny, Investigator Open-Mindedness

December 3, 1993